Skip to main content


Table 4 Summary of the response of 35 evaluated patients, divided into CR, PR, SD and PD.

From: Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer

Response No.(%)
Complete Response 4 (11)
Partial Response 7 (20)
Overall Response Rate (CR+PR) 11 (31)
Stable disease 15 (43)
Tumor control rate (CR+PR+SD) 26 (74)
Progressive disease 9 (26)